Determinants of subclinical diabetic heart disease

Diabetologia

Volumn 48, Issue 2, 2005, Pages 394-402

  Fang, Z Y ^a   Schull Meade, R ^a   Downey, M ^a   Prins, J ^a   Marwick, T H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Myocardial early diastolic velocity; Strain; Subclinical diabetes heart disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE DYSFUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REST; STRESS ECHOCARDIOGRAPHY; SYSTOLE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; MALE; METFORMIN; MIDDLE AGED; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 17444386290     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1632-z     Document Type: Article

References (34)

1. Kuller LH, Shemanski L, Psaty BM et al. (1995) Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 92:720-726
2. Poirier P, Garneau C, Bogaty P et al. (2000) Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 85:473-477
3. Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823-829
4. Fang ZY, Leano R, Marwick TH (2003) Relationship between longitudinal and radial contractility in subclinical heart disease. Clin Sci (Lond) 106:53-60
5. Naqvi TZ, Neyman G, Broyde A, Mustafa J, Siegel RJ (2001) Comparison of myocardial tissue Doppler with transmitral flow Doppler in left ventricular hypertrophy. J Am Soc Echocardiogr 14:1153-1160
6. Kukulski T, Jamal F, D'hooge J, Bijnens B, De SI, Sutherland GR (2002) Acute changes in systolic and diastolic events during clinical coronary angioplasty: a comparison of regional velocity, strain rate, and strain measurement. J Am Soc Echocardiogr 15:1-12
7. Andersen NH, Poulsen SH, Eiskjaer H, Poulsen PL, Mogensen CE (2003) Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. Clin Sci (Lond) 105:59-66
8. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JP, Marwick TH (2005) Screening for heart disease in diabetic subjects. Am Heart J (in press)
9. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
10. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP (1987) Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59:956-960
11. Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG (2003) Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr 16:906-921
12. Broderick TL, Kopp SJ, Daar JT, Romano FD, Paulson DJ (1994) Relation of glycosylated hemoglobin to in vivo cardiac function in response to dobutamine in spontaneously diabetic BB Wor rats. Can J Physiol Pharmacol 72:722-737
13. Hirai J, Ueda K, Takegoshi T, Mabuchi H (1992) Effects of metabolic control on ventricular function in type 2 diabetic patients. Intern Med 31:725-730
14. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG (2001) Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5-10
15. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51:1938-1948
16. Given MB, Lowe RF, Gelvin CR, Sander GE, Giles TD (1994) Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat. Am J Hypertens 7:919-925
17. Rosen R, Rump AF, Rosen P (1995) The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia 38:509-517
18. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S (1990) Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest 86:481-488
19. Fiorina P, La Rocca E, Astorri E et al. (2000) Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 23:1804-1810
20. Diamant M, Lamb HJ, Groeneveld Y et al. (2003) Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42:328-335
21. Stroedter D, Schmidt T, Bretzel RG, Federlin K (1995) Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol 32:235-243
22. Higuchi M, Uezu K, Sakanashi M (1993) Ex vivo effect of insulin on normal and diabetic rat hearts hypoperfused with norepinephrine. Eur J Pharmacol 242:293-300
23. Norton GR, Candy G, Woodiwiss AJ (1996) Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation 93:1905-1912
24. Petrova R, Yamamoto Y, Muraki K et al. (2002) Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. J Mol Cell Cardiol 34:1425-1431
25. Zhong Y, Ahmed S, Grupp IL, Matlib MA (2001) Altered SR Protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281: H1137-H1147
26. Thompson EW (1994) Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soc Exp Biol Med 205:294-305
27. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ (1996) Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes 45:1822-1825
28. Tsuji T, Mizushige K, Noma T et al. (2001) Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat. J Cardiovasc Pharmacol 38:868-874
29. Mathew P, John L, Jose J, Krishnaswami S (1992) Assessment of left ventricular diastolic function in young diabetics - a two dimensional echo Doppler study. Indian Heart J 44:29-32
30. Astorri E, Fiorina P, Contini GA et al. (1997) Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol 20:536-540
31. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ (1999) Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes 48:2059-2065
32. Jyothirmayi GN, Soni BJ, Masurekar M, Lyons M, Regan TJ (1998) Effects of metformin on collagen glycation and diastolic dysfunction in diabetic myocardium. J Cardiovasc Pharmacol Ther 3:319-326
33. Morel Y, Golay A, Perneger T et al. (1999) Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance. Diabet Med 16:650-655
34. Gudbjornsdottir S, Friberg P, Elam M, Attvall S, Lonnroth P, Wallin BG (1994) The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Press 3:394-403